U.S. Stock Sell-Off Deepens: Major Indices Slide for Fourth Straight Day, Led by Tech

Consumer Goods, Life Science, Technology

With Capital and Policy Working in Tandem, Biotechnology ETFs Present a Strategic Investment Opportunity

Life Science

AbbVie Stock Dips Post-Earnings, But Strong Immunology Pipeline and Dividend Offer Solid Foundation

Life Science

Trump Strikes Deal with Lilly and Novo Nordisk, Slashing Prices of Weight-Loss Drugs

Life Science

Why These Two Cannabis Stocks Are Gaining Attention？

Cannabis

Is Intuitive Surgical Stock a Buy? Here’s Why Cathie Wood and Izzy Englander Think So

Life Science, Technology

Amgen’s Strong Q3 Performance and Multi-Faceted Strategy Drive Long-Term Value

Life Science

Wall Street Snaps Up Three Healthcare Stocks as Each Surges Over 25%

Life Science

GLP-1 Price Cut Storm: Lilly and Novo Nordisk Engage in Strategic “Volume-for-Value” Game

Life Science

AstraZeneca Soars on Positive Trial Results for Hypertension Drug and Strong Earnings

Life Science

Hims & Hers Health Soars on Strong Growth and Strategic Shifts

Life Science

Metsera’s Impressive Clinical Data for Weight-Loss Drug Sparks Bidding War Among Pharma Giants

Life Science

U.S. Government Facilitates Historic Price Cut for Weight-Loss Drugs, with an Agreed Price of $245

Life Science

Novo Nordisk’s Weight-Loss Woes Worsen as It Cuts Guidance Again

Life Science

Teva Pharmaceutical’s Stock Soars on Better-Than-Expected Earnings

Life Science